Sort
30,917 grants matching “tumor microenvironment”
Molecular Determinants of Health Disparities in Inflammatory Breast Cancer
$478,055Gayathri Devi · Duke University · R01 · FY2022 · CA
SEMA6D-mediated breast cancer disparity, metastasis, and tumor-immune interaction
$478,030Lizhong Wang · University Of Alabama At Birmingham · R01 · FY2023 · CA
Epigenetic Effect of the Microenvironment on Stem Cell Plasticity and Function
$478,020Mary J.c. Hendrix · Lurie Children'S Hospital Of Chicago · R01 · FY2009 · CA
Metaplastic Tuft Cells in Pancreatic Cancer
$477,977Howard C Crawford · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Tumor-promoting liver injuries and mechanisms
$477,949Gen-Sheng Feng · University Of California, San Diego · R01 · FY2024 · CA
The role of the RNA demethylase FTO in metabolic reprogramming of renal cell carcinoma
$477,934Erinn B Rankin · Stanford University · R01 · FY2023 · CA
Novel immune suppressive activities of Fas/CD95 in triple negative breast cancer
$477,698Marcus E Peter · Northwestern University At Chicago · R01 · FY2025 · CA
Targeting stem-like cells and their niche in pancreatic cancer
$477,667Tuomas Tammela · Sloan-Kettering Inst Can Research · R37 · FY2023 · CA
Enhancing neoadjuvant chemotherpay responses with targeted T cells
$477,633Gerold Bepler · Wayne State University · R01 · FY2015 · CA
Mucosal T cell memory to pathogens
$477,507David Masopust · University Of Minnesota · R01 · FY2021 · AI
Mucosal T cell memory to pathogens
$477,507David Masopust · University Of Minnesota · R01 · FY2023 · AI
Mucosal T cell memory to pathogens
$477,507David Masopust · University Of Minnesota · R01 · FY2022 · AI
High throughput screening in human 3D spheroids of epithelial, endothelial, and s
$477,500Kristiina Vuori · Sanford Burnham Prebys Medical Discovery Institute · RC1 · FY2010 · EB
High throughput screening in human 3D spheroids of epithelial, endothelial, and s
$477,500Kristiina Vuori · Sanford Burnham Prebys Medical Discovery Institute · RC1 · FY2009 · EB
Exploring the potential of TET inhibition in cancer immunotherapy
$477,498Anjana Rao · La Jolla Institute For Immunology · R01 · FY2024 · CA
Center for Environment-Mediated Drug Resistance in Pediatric Cancer
$477,479Yves A Declerck · Children'S Hospital Of Los Angeles · U54 · FY2014 · CA
Hyaluronan Receptors in Prostate Cancer Progression
$477,467James B. McCarthy · University Of Minnesota · R01 · FY2010 · CA
Myoepithelial cell differentiation defects in ductal carcinoma in situ (DCIS)
$477,465Kornelia Polyak · Dana-Farber Cancer Inst · U01 · FY2011 · CA
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
$477,379Dai Fukumura · Massachusetts General Hospital · R01 · FY2018 · CA
Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment
$477,379Dai Fukumura · Massachusetts General Hospital · R01 · FY2020 · CA
Role of breast cancer-secreted miRNA in directing a stromal metabolic plasticity
$477,378Shizhen Emily Wang · University Of California, San Diego · R01 · FY2019 · CA
Therapeutically Targeting Ubiquitin Receptors in Multiple Myeloma
$477,256Kenneth C Anderson · Dana-Farber Cancer Inst · P50 · FY2021 · CA
Real time colon histopathology by infrared spectroscopic imaging
$477,213Rohit Bhargava · University Of Illinois At Urbana-Champaign · R01 · FY2025 · CA
Defining bone ecosystem effects on metastatic prostate cancer evolution and treatment response using an integrated mathematical modeling approach
$477,037Conor C Lynch · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2023 · CA
TGF-beta in Mammary Development and Tumorigenesis
$477,024Harold L Moses · Vanderbilt University · R01 · FY2010 · CA